Comparison of Outcomes Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Myocardial Infarction: A Meta-Analysis
Cureus · 30.10.2023
DOI: 10.7759/cureus.47954 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 30.10.2023. Verfasst von Johao Escobar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medicine, National Autonomous University of Honduras, San Pedro Sula, HND. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medicine, National Autonomous University of Honduras, San Pedro Sula, HND.
- Medicine, American College of Physicians, Philadelphia, USA.
- Interventional Cardiology, Himalayan Institute of Medical Sciences, Dehradun, IND.
- Medicine, National Autonomous University of Honduras, Tegucigalpa, HND.
- Telemetry, Sharp Memorial Hospital, San Diego, USA.
- Internal Medicine, Orotta School of Medicine and Dentistry, Asmara, ERI.
Zitieren
APA
Escobar, J., Rawat, A., Maradiaga, F., Isaak, A. K., Zainab, S., Arusi Dari, M., Mekonen Gdey, M., & Khan, A. (2023). Comparison of Outcomes Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Myocardial Infarction: A Meta-Analysis. Cureus. https://doi.org/10.7759/cureus.47954
Vancouver
Escobar J, Rawat A, Maradiaga F, Isaak AK, Zainab S, Arusi Dari M, et al. Comparison of Outcomes Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Myocardial Infarction: A Meta-Analysis. Cureus. 2023. doi:10.7759/cureus.47954
BibTeX
@article{Escobar2023,
author = {Escobar, Johao and Rawat, Anurag and Maradiaga, Fabricio and Isaak, Abraham K and Zainab, Sana and Arusi Dari, Mohammedsefa and Mekonen Gdey, Martha and Khan, Areeba},
title = {Comparison of Outcomes Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Myocardial Infarction: A Meta-Analysis},
journal = {Cureus},
year = {2023},
doi = {10.7759/cureus.47954}
}
EUVIMED